Breast cancer, a life-altering diagnosis for millions of women globally, remains one of the most researched areas in oncology. Among the various treatment modalities, hormone-responsive breast cancer therapies have seen significant breakthroughs. Aromatase inhibitors (AIs) have revolutionised the management of hormone receptor-positive breast cancers.
